Amarin to Present at the Deutsche Bank Securities Health Care Conference

DUBLIN and MYSTIC, Conn., April 27 /PRNewswire-FirstCall/ -- Amarin Corporation plc (Nasdaq: AMRN) today announced that John Thero, Chief Financial Officer, is scheduled to present at Deutsche Bank Securities 35th Annual Health Care Conference.  The presentation will be made on Monday, May 3, 2010 at 2:50 pm (Eastern Time). This conference will be held at the InterContinental Boston in Boston, Massachusetts, USA.

A live audio webcast of the presentation will be available at the following URL:  

http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=AMRN&item_id=3052069

About Amarin

Amarin is a clinical-stage biopharmaceutical company with expertise in lipid science focused the treatment of cardiovascular disease. The Company's lead product candidate is AMR101 (ethyl icosapentate), has commenced enrollment of patients in two pivotal Phase 3 clinical trials for the treatment of patients with very high triglyceride levels and for the treatment of patients with high triglycerides with mixed dyslipidemia. Both of these Phase 3 trials were designed under Special Protocol Assessment (SPA) agreements with the U.S. Food and Drug Administration (FDA). Amarin also has next-generation lipid candidates under evaluation for preclinical development. For more information please visit www.amarincorp.com.

SOURCE Amarin Corporation plc

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED